Lineage Cell Therapeutics Inc Net Asset Momentum
Lineage Cell Therapeutics Inc net asset momentum. Lineage Cell Therapeutics Inc (LCTX) recorded a net asset momentum of 24.2% as of December 2024, with net assets of $77.01 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore LCTX capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Lineage Cell Therapeutics Inc (1991–2024)
Net asset momentum of Lineage Cell Therapeutics Inc from 1991 to 2024. This chart tracks Lineage Cell Therapeutics Inc's year-over-year net asset growth across 34 annual reporting periods from 1991 to 2024. The most recent momentum reading is +24.2%, with net assets of $77.01 Million USD as of December 2024. See Lineage Cell Therapeutics Inc (LCTX) shareholders funds for net asset value and shareholders' equity analysis.
Lineage Cell Therapeutics Inc Net Asset Momentum by Year (1991–2024)
Lineage Cell Therapeutics Inc net asset momentum by year from 1991 to 2024. The table below shows the complete annual net asset history for Lineage Cell Therapeutics Inc from 1991 to 2024, covering 34 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Lineage Cell Therapeutics Inc stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $77.01 Million | $113.22 Million | $36.21 Million | ▲ +24.2% |
| 2023 | $62.02 Million | $101.02 Million | $39.00 Million | ▼ -13.8% |
| 2022 | $71.94 Million | $123.66 Million | $51.73 Million | ▼ -20.9% |
| 2021 | $90.90 Million | $174.54 Million | $83.65 Million | ▼ -4.4% |
| 2020 | $95.13 Million | $107.95 Million | $12.82 Million | ▼ -14.5% |
| 2019 | $111.25 Million | $125.48 Million | $14.23 Million | ▲ +20.6% |
| 2018 | $92.25 Million | $101.66 Million | $9.41 Million | ▼ -43.8% |
| 2017 | $164.26 Million | $173.24 Million | $8.98 Million | ▲ +25.9% |
| 2016 | $130.51 Million | $142.57 Million | $12.06 Million | ▲ +70.7% |
| 2015 | $76.45 Million | $94.66 Million | $18.21 Million | ▲ +21.9% |
| 2014 | $62.72 Million | $74.90 Million | $12.18 Million | ▲ +48.4% |
| 2013 | $42.26 Million | $57.73 Million | $15.47 Million | ▲ +74.0% |
| 2012 | $24.29 Million | $29.75 Million | $5.45 Million | ▼ -41.4% |
| 2011 | $41.46 Million | $45.83 Million | $4.37 Million | ▼ -16.1% |
| 2010 | $49.43 Million | $53.27 Million | $3.85 Million | ▲ +347.4% |
| 2009 | $11.05 Million | $13.43 Million | $2.39 Million | ▲ +354.1% |
| 2008 | $-4.35 Million | $1.04 Million | $5.38 Million | ▼ -42.7% |
| 2007 | $-3.05 Million | $175.10K | $3.22 Million | ▼ -63.3% |
| 2006 | $-1.87 Million | $650.51K | $2.52 Million | ▼ -848.8% |
| 2005 | $-196.58K | $1.96 Million | $2.16 Million | ▼ -157.0% |
| 2004 | $344.77K | $1.52 Million | $1.18 Million | ▲ +114.2% |
| 2003 | $-2.43 Million | $1.07 Million | $3.50 Million | ▼ -107.5% |
| 2002 | $-1.17 Million | $1.50 Million | $2.67 Million | ▼ -1081.9% |
| 2001 | $-99.09K | $1.94 Million | $2.04 Million | ▼ -107.5% |
| 2000 | $1.32 Million | $1.68 Million | $359.75K | ▼ -74.1% |
| 1999 | $5.08 Million | $5.68 Million | $595.51K | ▲ +111.8% |
| 1998 | $2.40 Million | $2.80 Million | $400.00K | ▼ -63.1% |
| 1997 | $6.50 Million | $8.30 Million | $1.80 Million | ▲ +132.1% |
| 1996 | $2.80 Million | $3.00 Million | $200.00K | ▲ +0.0% |
| 1995 | $2.80 Million | $3.00 Million | $200.00K | ▼ -12.5% |
| 1994 | $3.20 Million | $3.60 Million | $400.00K | ▼ -44.8% |
| 1993 | $5.80 Million | $5.90 Million | $100.00K | ▲ +70.6% |
| 1992 | $3.40 Million | $3.50 Million | $100.00K | ▼ -26.1% |
| 1991 | $4.60 Million | $4.80 Million | $200.00K | — |